Hexagon Capital Partners LLC Royalty Pharma PLC Transaction History
Hexagon Capital Partners LLC
- $508 Million
- Q3 2024
A detailed history of Hexagon Capital Partners LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 349 shares of RPRX stock, worth $9,283. This represents 0.0% of its overall portfolio holdings.
Number of Shares
349
Previous 336
3.87%
Holding current value
$9,283
Previous $8,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RPRX
# of Institutions
414Shares Held
283MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.09 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$1 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$612 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$429 Million0.35% of portfolio
-
Viking Global Investors LP12.1MShares$322 Million1.32% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.6B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...